REGN Stock Ownership Activity

REGENERON PHARMACEUTICALS 13F holders

5 value investing gurus have made changes to the REGENERON PHARMACEUTICALS (REGN) position according to the gurus' latest SEC quarterly report(s). REGN has been completely sold out by 1 guru(s), the number of REGN shares has been increased by 1, decreased by 3 super investor(s).

Which gurus or hedge funds are buying REGN now?

According to the latest SEC filing(s) REGENERON PHARMACEUTICALS (REGN) has been bought by Parnassus Investments - Parnassus Endeavor Fund (added shares +0.98%).

To see more about who is investing in REGENERON PHARMACEUTICALS (REGN), please go to the REGN ownership page.

2019 Q1 (1 result)
David M. Polen
+7.90%
+117,306
+0.25%
3.44%
Current price: $635.45 54.75% Reported price*: $410.62
2018 Q4 (1 result)
David M. Polen
-0.22%
-3,237
-0.01%
3.62%
Current price: $635.45 70.13% Reported price*: $373.50
2018 Q3 (1 result)
David M. Polen
+0.33%
+4,858
+0.01%
3.42%
Current price: $635.45 57.27% Reported price*: $404.04
2018 Q2 (1 result)
David M. Polen
+4.54%
+64,493
+0.14%
3.29%
Current price: $635.45 84.19% Reported price*: $344.99
2018 Q1 (1 result)
David M. Polen
+2.13%
+29,596
+0.07%
3.47%
Current price: $635.45 84.53% Reported price*: $344.36
2017 Q4 (1 result)
David M. Polen
+1.16%
+15,931
+0.04%
3.88%
Current price: $635.45 69.02% Reported price*: $375.96
2017 Q3 (1 result)
David M. Polen
-13.41%
-212,706
-0.77%
4.94%
Current price: $635.45 42.12% Reported price*: $447.12
2017 Q2 (1 result)
David M. Polen
+7.34%
+108,413
+0.47%
6.81%
Current price: $635.45 29.38% Reported price*: $491.14
2017 Q1 (1 result)
David M. Polen
+10.24%
+137,258
+0.49%
5.33%
Current price: $635.45 63.98% Reported price*: $387.51
2016 Q4 (1 result)
David M. Polen
+65.25%
+529,348
+2.14%
5.42%
Current price: $635.45 73.10% Reported price*: $367.09
2016 Q3 (1 result)
David M. Polen
+2.97%
+23,431
+0.11%
3.89%
Current price: $635.45 58.06% Reported price*: $402.02
2016 Q2 (1 result)
David M. Polen
+11.58%
+81,780
+0.36%
3.49%
Current price: $635.45 81.96% Reported price*: $349.23
2016 Q1 (1 result)
David M. Polen
+12.85%
+80,393
+0.40%
3.49%
Current price: $635.45 76.30% Reported price*: $360.44
2015 Q4 (1 result)
David M. Polen
+8.72%
+50,192
+0.42%
5.25%
Current price: $635.45 17.05% Reported price*: $542.87
2015 Q3 (1 result)
David M. Polen
+3.70%
+20,546
+0.18%
4.91%
Current price: $635.45 36.61% Reported price*: $465.14
2015 Q2 (1 result)
David M. Polen
-2.10%
-11,906
-0.12%
5.48%
Current price: $635.45 24.57% Reported price*: $510.13
2015 Q1 (1 result)
David M. Polen
+4.53%
+24,572
+0.22%
4.99%
Current price: $635.45 40.75% Reported price*: $451.48
2014 Q4 (2 results)
David M. Polen
-1.74%
-9,609
-0.08%
4.58%
Ole Andreas Halvorsen
-100.00%
-1,080,682
-1.79%
0.00%
Current price: $635.45 54.89% AVG reported price*: $410.25
2014 Q3 (2 results)
David M. Polen
+164.59%
+343,312
+2.78%
4.47%
Ole Andreas Halvorsen
-63.53%
-1,882,774
-2.73%
0.00%
Current price: $635.45 76.26% AVG reported price*: $360.52
2014 Q2 (2 results)
Ole Andreas Halvorsen
+181.75%
+1,911,656
+2.36%
3.65%
David M. Polen
-4.82%
-10,573
-0.07%
1.29%
Current price: $635.45 124.96% AVG reported price*: $282.47
2014 Q1 (2 results)
Ole Andreas Halvorsen
buy
+1,051,800
+1.32%
1.32%
David M. Polen
+12,416.45%
+217,412
+1.41%
1.42%
Current price: $635.45 111.62% AVG reported price*: $300.28
2013 Q2 (1 result)
David M. Polen
buy
+1,751
+0.01%
0.01%
Current price: $635.45 182.40% Reported price*: $225.01
26 of 76

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.